Article Publication Date:
This issue brief reviews the structure of the prescription drug benefit in Medicaid and the traditional policy levers states have used to control drug spending. It also describes state strategies to contain costs, such as efforts to obtain greater rebates, actions concerning generic drugs and biosimilar alternatives, transparency laws and new efforts to draw on federal resources.
Sources:Kaiser Family Foundation
- Henry J. Kaiser Family Foundation
Short URL: http://www.advancingstates.org/node/70195